Why the study?
Elderly patients with severe AS require individualized decision-making to optimize survival and quality of life, and frailty must be considered when weighing treatment options.
Does a tailored interventional treatment using frailty-based management improve long-term survival and functional status in elderly patients with severe aortic stenosis?
Does a tailored interventional treatment using frailty-based management improve long-term survival and functional status in elderly patients with severe aortic stenosis?
A tailored frailty-based management approach in elderly patients with severe aortic stenosis helps predict long-term survival and functional status, demonstrating that TAVR and pre-frail status are associated with better outcomes at 6 years.
Frailty-based stratification may inform individualized AS decisions in elderly patients; leaves open whether it improves long-term outcomes versus standard care.
Background: Elderly patients with severe aortic stenosis (AS) need individualized decision-making in their management in order to benefit in terms of survival and improvement of quality of life. Frailty, a common condition in elderly patients, needs to be considered when weighing treatment options. Aim: We aimed to evaluate outcomes including survival and functional parameters according to disability criteria at six years of follow-up in an older population treated for severe AS using a frailty-based management. Methods: We evaluated data derived from a pilot clinical project involving elderly patients with severe AS referred to a tailored management based on classification by Fried’s score into pre-frail, early frail, and frail and a multidimensional geriatric assessment. A Frailty, Inflammation, Malnutrition, and Sarcopenia (FIMS) score was used to predict the risk of mortality at six years of follow-up. Functional status was evaluated by telephonic interview. Results: At six years of follow-up, we found a survival rate of 40%. It was higher in the pre-frail patients (long rank < 0.001) and in the patients who underwent TAVR treatment (long rank < 0.001). The cut-off FIMS score value of ≥1.28 was an independent determinant associated with a higher risk of mortality at six years of follow-up (HR 2.91; CI 95% 1.7–5.1; p-value 0.001). We found a moderate increase of disability levels, malnutrition status, comorbidities, and number of drugs, but none of them self-reported advanced NYHA class III–IV heart failure. Conclusion: An accurate clinical–instrumental and functional geriatric evaluation in an elderly population with AS is required for a non-futile interventional treatment in terms of survival and functional status even in long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Esposito et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: